chr1-155250371-G-A

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate

The NM_006589.3(ENTREP3):​c.1415C>T​(p.Pro472Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000055 in 1,545,284 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000079 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000052 ( 0 hom. )

Consequence

ENTREP3
NM_006589.3 missense

Scores

2
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.50

Publications

0 publications found
Variant links:
Genes affected
ENTREP3 (HGNC:1233): (endosomal transmembrane epsin interactor 3) This gene is located near the gene for the lysosomal enzyme glucosylceramidase; a deficiency in this enzyme is associated with Gaucher disease. The encoded protein has been identified as a potential binding partner of a WW domain-containing protein which is involved in apoptosis and tumor suppression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.17391777).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ENTREP3NM_006589.3 linkc.1415C>T p.Pro472Leu missense_variant Exon 9 of 12 ENST00000361361.7 NP_006580.2 P81408-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ENTREP3ENST00000361361.7 linkc.1415C>T p.Pro472Leu missense_variant Exon 9 of 12 1 NM_006589.3 ENSP00000354958.2 P81408-1

Frequencies

GnomAD3 genomes
AF:
0.0000788
AC:
12
AN:
152190
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000957
GnomAD2 exomes
AF:
0.0000627
AC:
9
AN:
143460
AF XY:
0.0000262
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000206
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000773
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000524
AC:
73
AN:
1393094
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
37
AN XY:
687228
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
31096
American (AMR)
AF:
0.000283
AC:
10
AN:
35326
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
24926
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35328
South Asian (SAS)
AF:
0.0000127
AC:
1
AN:
78898
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48406
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4100
European-Non Finnish (NFE)
AF:
0.0000520
AC:
56
AN:
1077392
Other (OTH)
AF:
0.000104
AC:
6
AN:
57622
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000788
AC:
12
AN:
152190
Hom.:
0
Cov.:
32
AF XY:
0.0000538
AC XY:
4
AN XY:
74358
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41456
American (AMR)
AF:
0.000458
AC:
7
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68022
Other (OTH)
AF:
0.000957
AC:
2
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000853
Hom.:
0
Bravo
AF:
0.000249

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
May 28, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1415C>T (p.P472L) alteration is located in exon 9 (coding exon 9) of the FAM189B gene. This alteration results from a C to T substitution at nucleotide position 1415, causing the proline (P) at amino acid position 472 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.39
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.025
.;.;T
Eigen
Uncertain
0.35
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Benign
0.62
D
M_CAP
Benign
0.018
T
MetaRNN
Benign
0.17
T;T;T
MetaSVM
Benign
-0.71
T
MutationAssessor
Benign
0.55
.;.;N
PhyloP100
3.5
PrimateAI
Pathogenic
0.91
D
PROVEAN
Benign
-1.2
N;N;N
REVEL
Benign
0.099
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.011
D;D;D
Polyphen
1.0
D;.;D
Vest4
0.29
MVP
0.40
MPC
2.8
ClinPred
0.23
T
GERP RS
4.3
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.12
gMVP
0.34
Mutation Taster
=95/5
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1000466806; hg19: chr1-155220162; API